- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT01967992
Examining the Effects of Diet on Health With an Online Program
Panoramica dello studio
Stato
Condizioni
Descrizione dettagliata
Tipo di studio
Iscrizione (Effettivo)
Fase
- Fase 2
Contatti e Sedi
Luoghi di studio
-
-
California
-
San Francisco, California, Stati Uniti, 94115
- University of California, San Francisco
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- HbA1c 6.5%-9% at screening.
- Aged 18 years old and older
- BMI 25 and above.
- Willing and able to participate in the interventions such as having sufficient control over their food intake. Must have the ability to make choices about the food they eat; cannot have a lifestyle in which they eat out most of their meals.)
Exclusion Criteria:
- Unable to provide informed consent.
- Non English speaker.
- No current use of insulin, no immediate plans to start or increase diabetic mediations, and no use of diabetes medications besides metformin.
- A substance abuse, mental health, or medical condition that, in the opinion of investigators, will make it difficult for the potential participant to participate in the intervention. Such conditions may include: cancer, liver failure, unstable coronary artery disease, severe emphysema, binge eating disorder or history of binge eating disorder, bulimia or strong history of bulimia.
- Previous use or recent changes in medications that can interfere with the measures used in the study: current use of insulin; use of systemic (oral or IV) corticosteroids in the 6 months prior to enrollment or severe autoimmune disorders or other conditions (e.g. rheumatoid arthritis, lupus), that are likely to require these medications; and initiation of new class of psychiatric medications in past 2 months.
- Pregnant or planning to get pregnant in the next 12 months, breastfeeding or less than 6 months post-partum.
- Current use of weight loss medications or supplements such as Alli or amphetamine-based drugs that are believed to have some effect on weight.
- History of or planned weight loss surgery.
- Vegan or vegetarian. The intervention diets are more challenging for vegan and vegetarian participants.
- No or very limited internet access at a computer. Must be able to complete the online assessments and access the online class materials.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Separare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Comparatore attivo: American Diabetes Association recommended diet
Participants in the American Diabetes Association (ADA) diet group will receive standard ADA advice.
The diet includes high-fiber foods (such as vegetables, fruits, whole grains, and legumes), low-fat dairy products, fresh fish, and foods low in saturated fat.
They will be asked to use the "plate method" to guide their nutritional choices.
|
|
|
Sperimentale: Low Carbohydrate Diet
Participants will be instructed to follow a low carbohydrate, ketogenic diet: carbohydrate intake 20-35 grams a day not including fiber. Foods permitted include: meats, poultry, fish, eggs, cheese, cream, some nuts and seeds, green leafy vegetables, and most other non-starchy vegetables. Because most individuals self-limit caloric intake, no calorie restriction will be recommended. Participants will also be taught information about mindfulness and positive affect practices. The mindfulness-based curriculum will focus on the following elements: training on topics such as mindful meditation, mindful eating, awareness of fullness and hunger signals, and taste satiety. The positive emotion curriculum will include: training on topics such as noticing and savoring positive events, gratitude, positive reappraisal, personal strengths, attainable goals, and acts of kindness. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Hemoglobin A1c
Lasso di tempo: baseline to 16 weeks
|
We will test whether Hemoglobin A1c changes from pre-intervention to 16 weeks.
The key outcome measure will compare the two groups, but we will also assess whether statistically significant changes occur within groups from pre-intervention to 16 weeks.
|
baseline to 16 weeks
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Hemoglobin A1c
Lasso di tempo: baseline to 32 weeks
|
We will test whether Hemoglobin A1c changes from pre-intervention to 32 weeks.
The key outcome measure will compare the two groups, but we will also assess whether statistically significant changes occur within groups from pre-intervention to 32 weeks.
|
baseline to 32 weeks
|
Altre misure di risultato
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Body weight
Lasso di tempo: baseline to 16 weeks
|
We will test whether body weight changes from pre-intervention to 16 weeks.
The key outcome measure will compare the two groups, but we will also assess whether statistically significant changes occur within groups from pre-intervention to 16 weeks.
|
baseline to 16 weeks
|
|
Body weight
Lasso di tempo: baseline to 32 weeks
|
We will test whether body weight changes from pre-intervention to 32 weeks.
The key outcome measure will compare the two groups, but we will also assess whether statistically significant changes occur within groups from pre-intervention to 32 weeks.
|
baseline to 32 weeks
|
Collaboratori e investigatori
Investigatori
- Investigatore principale: Rick Hecht, MD, University of California, San Francisco
- Investigatore principale: Laura R Saslow, PhD, University of Michigan
Pubblicazioni e link utili
Collegamenti utili
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Altri numeri di identificazione dello studio
- 13-11813
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Diabete di tipo 2
-
AmgenCompletato
-
Fudan UniversityShanghai Cancer Hospital, ChinaNon ancora reclutamento
-
Istituto Oncologico Veneto IRCCSReclutamentoGlioblastoma | Glioblastoma IDH wild-type e Stat3-positiviItalia
-
Oncology Institute of Southern SwitzerlandUniversity of Kiel; Ente Ospedaliero Cantonale, BellinzonaCompletato
-
Henan Cancer HospitalCompletatoCancro colorettale metastatico KRAS, NRAS e BRAF V600E wild-type
-
Hospital Universitari de BellvitgeInstitut d'Investigació Biomèdica de BellvitgeNon ancora reclutamentoArresto cardiaco | Cardiomiopatia amiloide | ATTR Amiloidosi Wild Type | Mutazione del gene ATTR
-
AmgenCompletatoCancro colorettale metastatico RAS wild-type
-
Yonsei UniversityNon ancora reclutamentoRAS/BRAF Wild-Type Advanced Cancer MathementCorea, Repubblica di
-
Rosemary Claire RodenChildren's Miracle NetworkTerminatoBulimia nervosa | Comportamento impulsivo | Eliminazione (disturbi alimentari) | Problemi alimentari | Disturbi alimentari in adolescenza | Anoressia Nervosa/Bulimia | Anoressia in adolescenza | Anoressia Nervosa, Atipica | Anoressia Nervosa, Binge Eating/Purging TypeStati Uniti
-
Denver Health and Hospital AuthorityCompletatoDisturbo evitante restrittivo dell'assunzione di cibo | Anoressia Nervosa, Binge Eating/Purging Type | ARFIDE | Tipo restrittivo di anoressia nervosaStati Uniti
Prove cliniche su Dieta dell'American Diabetes Association
-
Physicians Committee for Responsible MedicineCompletato
-
University of California, San FranciscoCompletatoSindrome dell'Ovaio PolicisticoStati Uniti
-
University of California, San FranciscoCompletatoDiabete di tipo IIStati Uniti
-
Mondelēz International, Inc.KGK Science Inc.Completato
-
University of BeykentCompletato
-
Johnson & Johnson Consumer Inc. (J&JCI)Completato
-
Johnson & Johnson Consumer Inc. (J&JCI)Completato
-
University of California, DavisUSDA, Western Human Nutrition Research CenterCompletato